ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company logo

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Employee Directory

Biotechnology ResearchUnited States201-500 Employees

ImClone Systems is a United States–based biotechnology company focused on cancer research and development. It develops and brings to market targeted biologic medicines intended to address the medical needs of patients with various cancers, operating as a fully integrated, global biopharmaceutical organization. Since 2008, the company has been a wholly owned subsidiary of Eli Lilly and Company, aligning it with Lilly’s oncology initiatives. The company has emphasized monoclonal antibodies as a therapeutic approach for cancer. In 2020, reporting notes that ImClone is actively developing monoclonal antibodies for cancer treatment, reflecting ongoing progress within its oncology portfolio.

Find ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company employees' phone numbers or email addresses

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Global Highlights

Location
Employees

North America
564

Minus sign iconPlus sign icon
  • United States Of America
    563
  • Canada
    1

Europe
15

Minus sign iconPlus sign icon
  • United Kingdom Of Great Britain And Northern Ireland
    8
  • France
    5
  • Spain
    1
  • Sweden
    1

Asia
7

Minus sign iconPlus sign icon
  • India
    4
  • China
    2
  • Iran
    1

Africa
1

Minus sign iconPlus sign icon
  • Nigeria
    1

South America
1

Minus sign iconPlus sign icon
  • Argentina
    1

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company's Leadership

  • Stylized image of a person
    V. L.
    Chief Of Maintenance
    Phone icon
  • Stylized image of a person
    D. S.
    Vice President Operations
    Phone icon
  • Stylized image of a person
    M. J.
    Vice President
    Phone icon
  • Stylized image of a person
    D. P.
    Director, Gxp Compliance
    Phone icon
  • Stylized image of a person
    A. K.
    Director
    Phone icon
  • Stylized image of a person
    B. J.
    Senior Director
    Phone icon
  • Stylized image of a person
    J. G.
    Director Of Administrative Services
    Phone icon
  • Stylized image of a person
    K. B.
    Director Of Finance, Research And Development
    Phone icon

ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company Employee Metrics

100%
50%
0%
2026
2025
  • Biotechnology
  • Administrative
  • Quality Assurance
  • Operations
  • Legal
  • Other
  • Supply Chain

Contact profiles from ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    R. M.
    Senior Director
    Phone icon
    Oct 17, 2024
  • Stylized image of a person
    R. T.
    Director
    Phone icon
    Oct 26, 2023
  • Stylized image of a person
    R. F.
    Director Of Operations
    Phone icon
    Oct 17, 2024
  • Stylized image of a person
    T. C.
    Director
    Phone icon
    Apr 07, 2025
  • Stylized image of a person
    Y. H.
    Senior Director Tumor Biology
    Phone icon
    Oct 17, 2024
  • Stylized image of a person
    T. R.
    Associate Director Global Patient Safety
    Phone icon
    Jun 01, 2026
  • Stylized image of a person
    M. W.
    Product Manager
    Phone icon
    IndiaMaharashtra
    Nov 12, 2025
  • Stylized image of a person
    X. W.
    Manager
    Phone icon
    ChinaJiangsu
    May 30, 2026
  • Stylized image of a person
    H. T.
    Territory Manager
    Phone icon
    IndiaMaharashtra
    Sep 12, 2025
  • Stylized image of a person
    A. F.
    Manager
    Phone icon
    Oct 18, 2024

Frequently Asked Questions

What is ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company known for?

Minus sign iconPlus sign icon
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company was founded in 9184 operates in the Biotechnology Research industry; you can contact the main corporate office by phone at . Explore ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company's company overview page for more information.

What is ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company's most common email format?

Minus sign iconPlus sign icon
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company email formats with LeadIQ.

How many employees does ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company have currently?

Minus sign iconPlus sign icon
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company has approximately 371 employees as of July 2026. These team members are located across 5 continents, including North AmericaEuropeAsia.

Who are ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company's key employees and leadership?

Minus sign iconPlus sign icon

As of July 2026, ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company's key employees include:

  • Chief Of Maintenance: V. L.
  • Vice President Operations: D. S.
  • Vice President: M. J.
  • Director, Gxp Compliance: D. P.
  • Director: A. K.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.